Merilog SoloStar insulin pen (insulin aspart-szjj) with a labeled dosage of 100 units/mL (U-100). The pen is a 3 mL prefilled injection device for single-patient use. The label indicates it is available by prescription only. Courtesy of FDA and Sanofi. Graphic design by Zebulon Rogerson.

The FDA has approved Merilog, the first rapid-acting insulin biosimilar to NovoLog, enhancing diabetes treatment options and affordability.

jcst2d.com/index.php?vi...

#FDAApproval #Merilog #InsulinBiosimilar #DiabetesCare #NovoLog

The U.S. Food and Drug Administration (FDA) has approved Merilog, the first rapid-acting insulin biosimilar to Novolog (insulin aspart), providing a new option for diabetes management.

#DiabetesCare #FDAApproval #Merilog #InsulinBiosimilar #HealthTech #MedicalInnovation